Brief: Repare Therapeutics Announces Plenary Oral Presentation At The 2023 Aacr Annual Meeting On Camonsertib And Additional Data Presentations On Rp-6306
14/03/2023 22:46
March 14 (Reuters) - Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS ANNOUNCES PLENARY ORAL PRESENTATION AT
THE
2023 AACR ANNUAL MEETING ON CAMONSERTIB AND ADDITIONAL DATA
PRESENTATIONS ON RP-6306
Source text for Eikon: ID:nBw272XDpa
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln